Drug Information Association Logo

A Regulatory Informatics Approach to Identifying Trends in Minimal Residual Disease for the Hematologic Malignancies

Time

Tue, Jun 17 7:15AM
T 18

Title

A Regulatory Informatics Approach to Identifying Trends in Minimal Residual Disease for the Hematologic Malignancies

Abstract Summary

We performed advanced searches in the Clinicaltrials.gov Registry (dated 30 January 2014) and analyzed the results using ActivePerl (v5.12.2) and R (v2.13.0). The numbers of clinical trials for efficacy endpoints, indications, and technologies were assessed using trial start dates or cumulative sums.

Poster Presenter

Elizabeth Rach
Senior Associate, Global Regulatory Affairs, Oncology,
Janssen R&D, LLC
United States